Position in DNA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$610,624
+$302,390 QoQ
Shares Held
61,617
+22.5% QoQ
Ownership
0.092%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 183 holders
Holding Since
Dec 2021
16 quarters on record
Voting authority
Sole 16%
Shared 0%
None 84%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. DNA ranks #167 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in DNA
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $610,624 | 61,617 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $308,234 | 50,283 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $406,118 | 48,871 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $845,362 | 57,981 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $666,337 | 59,230 | Shares | Sole | 2025-08-12 | |
| 2024-06-30 | $46,980 | 140,659 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,708,203 | 1,472,589 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,829,467 | 1,674,241 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $2,936,375 | 1,622,307 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $3,023,735 | 1,625,664 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,203,344 | 904,770 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,432,716 | 847,761 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,318,319 | 743,051 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,765,005 | 741,599 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $182,228 | 45,218 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $375,761 | 45,218 | Shares | Sole | 2022-02-10 | |
| No filing history on record for this holder in this stock. | ||||||